Lyell Immunopharma Inc
NASDAQ:LYEL
Income Statement
Earnings Waterfall
Lyell Immunopharma Inc
Revenue
|
130k
USD
|
Operating Expenses
|
-247.1m
USD
|
Operating Income
|
-247m
USD
|
Other Expenses
|
12.4m
USD
|
Net Income
|
-234.6m
USD
|
Income Statement
Lyell Immunopharma Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
8
N/A
|
9
+15%
|
8
-5%
|
10
+20%
|
11
+5%
|
9
-18%
|
42
+378%
|
39
-7%
|
85
+117%
|
84
-1%
|
48
-42%
|
49
+0%
|
0
-100%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(220)
|
(243)
|
(203)
|
(217)
|
(225)
|
(273)
|
(281)
|
(259)
|
(272)
|
(265)
|
(258)
|
(251)
|
(247)
|
|
Selling, General & Administrative |
(47)
|
(55)
|
(64)
|
(72)
|
(89)
|
(107)
|
(118)
|
(123)
|
(117)
|
(102)
|
(91)
|
(80)
|
(67)
|
|
Research & Development |
(182)
|
(198)
|
(148)
|
(155)
|
(135)
|
(137)
|
(131)
|
(138)
|
(164)
|
(171)
|
(178)
|
(183)
|
(186)
|
|
Other Operating Expenses |
9
|
10
|
9
|
10
|
(1)
|
(30)
|
(32)
|
2
|
10
|
8
|
11
|
12
|
6
|
|
Operating Income |
(212)
N/A
|
(234)
-11%
|
(194)
+17%
|
(207)
-6%
|
(214)
-4%
|
(264)
-23%
|
(239)
+10%
|
(220)
+8%
|
(187)
+15%
|
(181)
+3%
|
(210)
-16%
|
(202)
+4%
|
(247)
-22%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
6
|
4
|
2
|
1
|
1
|
1
|
2
|
3
|
6
|
10
|
14
|
20
|
23
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(37)
|
0
|
0
|
(41)
|
(5)
|
(15)
|
(18)
|
(13)
|
(13)
|
|
Total Other Income |
2
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
3
|
4
|
4
|
5
|
2
|
|
Pre-Tax Income |
(204)
N/A
|
(230)
-13%
|
(192)
+17%
|
(205)
-7%
|
(250)
-22%
|
(263)
-5%
|
(237)
+10%
|
(258)
-9%
|
(183)
+29%
|
(182)
+1%
|
(210)
-15%
|
(190)
+9%
|
(235)
-23%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(204)
|
(230)
|
(192)
|
(205)
|
(250)
|
(263)
|
(237)
|
(258)
|
(183)
|
(182)
|
(210)
|
(190)
|
(235)
|
|
Net Income (Common) |
(204)
N/A
|
(230)
-13%
|
(192)
+17%
|
(205)
-7%
|
(250)
-22%
|
(263)
-5%
|
(237)
+10%
|
(258)
-9%
|
(183)
+29%
|
(182)
+1%
|
(210)
-15%
|
(190)
+9%
|
(235)
-23%
|
|
EPS (Diluted) |
-0.84
N/A
|
-0.95
-13%
|
-0.8
+16%
|
-0.85
-6%
|
-1.03
-21%
|
-1.07
-4%
|
-0.96
+10%
|
-1.04
-8%
|
-0.73
+30%
|
-0.73
N/A
|
-0.84
-15%
|
-0.76
+10%
|
-0.93
-22%
|